| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Genscript Corporation
|
799.999m | 36.58% | — | Jun 16 2025 |
| 2 |
Hillhouse Investment Management Limited
|
173.349m | 7.93% | — | Apr 23 2025 |
| 3 |
Norges Bank Investment Management (NBIM)
|
48.936m | 2.24% | +26.362m | Dec 31 2025 |
| 4 |
China Universal Asset Management Co., Ltd.
|
45.798m | 2.09% | +30.476m | Dec 31 2025 |
| 5 |
GF Fund Management Co., Ltd.
|
39.408m | 1.80% | +12.442m | Dec 31 2025 |
|
1
Genscript Corporation
|
36.58%
799.999m
|
|
2
Hillhouse Investment Management Limited
|
7.93%
173.349m
|
|
3
Norges Bank Investment Management (NBIM)
|
2.24%
48.936m
|
|
4
China Universal Asset Management Co., Ltd.
|
2.09%
45.798m
|
|
5
GF Fund Management Co., Ltd.
|
1.80%
39.408m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 50.64% of Genscript Biotech Corp, with Genscript Corporation the biggest at 36.58%, followed by Hillhouse Investment Management Limited (7.93%) and Norges Bank Investment Management (NBIM) (2.24%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


